MYGN ▼ -1.8% - Myriad Genetics, Inc.
$MYGN - Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
22-OCT-2026 09:05 AM ET
Share this post
More filings for $MYGN
MYGN ▲ +10.7% - Myriad Genetics, Inc.Oct 20, 2026MYGN ▲ +10.7% - Myriad Genetics, Inc.Oct 20, 2026MYGN ▲ +4.8% - Myriad Genetics, Inc.Oct 15, 2026MYGN ▼ -1.2% - Myriad Genetics, Inc.Oct 8, 2026MYGN - Myriad Genetics, Inc. - SEC Filing Update (04-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 4, 2026MYGN ▲ +1.3% - Myriad Genetics, Inc.Aug 27, 2026
View full $MYGN filing history →💬 Comments
Loading comments…
Leave a comment